BRIEF published on 03/17/2026 at 07:08, 1 month 13 days ago Sartorius Stedim Biotech Sets New Growth Targets with Biopharma Focus Advanced Therapies Market Expansion Growth Targets Biopharma Strategy Bioprocessing Technologies
PRESS RELEASE published on 03/17/2026 at 07:03, 1 month 13 days ago Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets Sartorius Stedim Biotech sharpens focus on biopharma with new growth targets and strategic initiatives to drive above-market growth and margin expansion Sartorius Stedim Biotech Strategic Initiatives Growth Targets Biopharma Above-market Growth
BRIEF published on 03/02/2026 at 16:30, 1 month 28 days ago Sartorius Stedim Biotech: Statement on Share Capital Share Capital Voting Rights Actions Sartorius Stedim Biotech AMF Regulations
BRIEF published on 03/02/2026 at 16:30, 1 month 28 days ago Sartorius Stedim Biotech: Share Capital and Voting Rights Update Share Capital Voting Rights French Commercial Code Sartorius Stedim Biotech EQS News Service
PRESS RELEASE published on 03/02/2026 at 16:25, 1 month 28 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in issued capital as of February 28, 2026 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech
PRESS RELEASE published on 02/16/2026 at 09:13, 2 months 14 days ago Sartorius Stedim Biotech releases Universal Registration Document 2025 Sartorius Stedim Biotech releases Universal Registration Document 2025, providing insights into its financial performance and strategic outlook for the future Financial Report Sartorius Stedim Biotech Annual Results Universal Registration Document Biopharma Industry
BRIEF published on 02/16/2026 at 09:13, 2 months 14 days ago Sartorius Stedim Biotech Releases 2025 Universal Registration Document Global Operations Sartorius Stedim Biotech Universal Registration Document Biopharmaceutical Solutions 2025 Financials
BRIEF published on 02/16/2026 at 09:13, 2 months 14 days ago Sartorius Stedim Biotech publishes its 2025 Universal Registration Document Consolidated Financial Statements Sartorius Stedim Biotech Universal Registration Document Fiscal Year 2025 2026 Objectives
PRESS RELEASE published on 02/16/2026 at 09:09, 2 months 14 days ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech releases Universal Registration Document 2025 with business development and financial statements. Leading biopharmaceutical partner based in Aubagne, France Financial Statements Business Development Sartorius Stedim Biotech Biopharmaceutical Industry Universal Registration Document
PRESS RELEASE published on 02/16/2026 at 09:08, 2 months 14 days ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech Group's Universal Registration Document 2025 now available at the provided link. Includes fiscal 2025 business development, 2026 forecast, and financial statements Financial Statements Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry Universal Registration Document 2025
Published on 04/30/2026 at 16:00, 1 hour 41 minutes ago CORRECTION FROM SOURCE: Rio Grande Resources Announces Results from its Airborne Survey at Winston Gold/Silver Project, New Mexico and Announces New President
Published on 04/30/2026 at 15:35, 2 hours 6 minutes ago Nepra Foods Enters Letter of Intent to Acquire Idaho Bottling and Water Assets, Advancing Vertical Integration Strategy
Published on 04/30/2026 at 15:10, 2 hours 31 minutes ago Formation Metals Announces Non-Brokered Offering of up to $15 Million Fully Allocated
Published on 04/30/2026 at 15:00, 2 hours 41 minutes ago Wi2Wi Corporation Announces Grant of Options
Published on 04/30/2026 at 15:00, 2 hours 41 minutes ago Karbon-X Advances Sur del Meta REDD+ Project with Biodiversity Partnership
Published on 04/30/2026 at 17:20, 20 minutes ago NABA, NUOVA ACCADEMIA DI BELLE ARTI EXPANDS IN LONDON AND STRENGTHENS ITS PRESENCE IN THE UK MARKET WITH THE APPOINTMENT OF DIEGO MATTIOLO
Published on 04/30/2026 at 17:02, 39 minutes ago Verve announces the publication of its Annual and Sustainability Report for 2025
Published on 04/30/2026 at 16:33, 1 hour 7 minutes ago Annual Report and Audited Accounts to 31 December 2025
Published on 04/30/2026 at 07:45, 9 hours 56 minutes ago The Belgian State and ENGIE Group enter into exclusive negotiations for the acquisition by Belgium of ENGIE's nuclear activities
Published on 04/30/2026 at 07:30, 10 hours 11 minutes ago New Gimv Anchor investment: acquisition of 5% shareholding in Azelis
